Valérie Gafner

An Effector-Reduced Anti- -Amyloid (A ) Antibody with Unique A  Binding Properties Promotes Neuroprotection and Glial Engulfment of A 

Oskar Adolfsson, Maria Pihlgren, Nicolas Toni et al. · Journal of Neuroscience · 2012 · 310 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Efficacy and Safety of A Liposome-Based Vaccine against Protein Tau, Assessed in Tau.P301L Mice That Model Tauopathy

Clara Theunis, Natàlia Crespo‐Biel, Valérie Gafner et al. · PLoS ONE · 2013 · 252 citations · Full text

Life Sciences, Biotechnology, Immunology +17

Antibody-Mediated Targeting of Tau In Vivo Does Not Require Effector Function and Microglial Engagement

Seung-Hye Lee, Claire E. Le Pichon, Oskar Adolfsson et al. · Cell Reports · 2016 · 132 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Pharmacokinetics and safety of panobacumab: specific adjunctive immunotherapy in critical patients with nosocomial Pseudomonas aeruginosa O11 pneumonia

Qin Lü, Jean‐Jacques Rouby, P F Laterre et al. · Journal of Antimicrobial Chemotherapy · 2011 · 64 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

TLR4- and TRIF-dependent stimulation of B lymphocytes by peptide liposomes enables T cell–independent isotype switch in mice

Maria Pihlgren, Alberto B. Silva, Rime Madani et al. · Blood · 2012 · 44 citations · Full text

Life Sciences, Immunology, Molecular Biology +16